Table 5.
Levels of Evidence: Quality of Psychometric Properties and Feasibility of Tests in Articles Identified During Phase II
| Test | Internal Consistency | Reliability | Content Validity | Structural Validity | Hypothesis Testing | Criterion Validity | Responsiveness | Feasibility |
|---|---|---|---|---|---|---|---|---|
| Executive | ||||||||
| Category fluency tests | ? | |||||||
| Phonemic fluency tests | ? | ? | ||||||
| Learning memory | ||||||||
| Prospective memory test | ? | |||||||
| Social cognition | ||||||||
| Awareness of Social Inference Test | ++ | |||||||
| Ekman 60 Faces Test | ? | |||||||
| Reading the Mind in the Eyes Test | +++ | +++ | ||||||
| Screening test | ||||||||
| Addenbrooke’s Cognitive Examination | ? | ? | +++ | ? | + | x | ||
| ALS Brief Cognitive Assessment | ? | |||||||
| ALS Cognitive Behavioural Screen | ? | x | ||||||
| Edinburgh Cognitive and Behavioural ALS Screen | ? | ? | ++ | ++ | ? | x | ||
| Frontal Assessment Battery | +++ | ? | + | x | ||||
| Mini-Mental State Examination | +/- | |||||||
| Montreal Cognitive Assessment | ++ | ? | x | |||||
| Penn State Brief Exam of Frontal and Temporal Dysfunction Syndromes | ||||||||
| University of California San Francisco Screening Battery | ? | + | ? | |||||
| Test batteries a | ||||||||
| ALS-Computerized Frontal Battery | ? | |||||||
| Battery I | ? | x | ||||||
| Battery II | ? | ? | ||||||
| Battery III | ? | |||||||
| Battery IV | ? | + | ||||||
| Battery V | ? | |||||||
| Communicative Participation Item Bank | + | ? | ? | |||||
| Mental Deterioration Battery | + |
Notes: +++ or — = Strong evidence with consistent positive or negative results from multiple studies with good methodological quality or one study with excellent methodological quality. ++ or – = Moderate evidence with consistent positive or negative results from multiple studies with fair methodological quality or one study with good quality. + or - = Limited evidence with positive or negative results from a study with fair methodological quality. +/− = Conflicting evidence with conflicting results from individual studies. ? = Unknown level of evidence due to results from studies with poor methodological quality. x =Feasibility was evaluated. Gray-highlighted box indicate high to moderate level of evidence. aBatteries I–V were developed specifically for use in patients with ALS.
Abbreviation: ALS, amyotrophic lateral sclerosis.